P

Inventor

CHAI WENYING

US31 patents
⚠️ This page may combine multiple inventors who share the name “CHAI WENYING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

22 patents
US9079911B2Jul 14, 2015

Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators

JANSSEN PHARMACEUTICA NV13 citations92
US11059828B2Jul 13, 2021

Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators

JANSSEN PHARMACEUTICA NV3 citations83
US10981911B2Apr 20, 2021

Imidazopyrrolopyridine as inhibitors of the JAK family of kinases

JANSSEN PHARMACEUTICA NV6 citations83
US11827638B2Nov 28, 2023

Imidazopyrrolopyridine as inhibitors of the JAK family of kinases

JANSSEN PHARMACEUTICA NV2 citations72
US11667644B2Jun 6, 2023

Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators

JANSSEN PHARMACEUTICA NV2 citations72
USRE48841EDec 7, 2021

Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators

JANSSEN PHARMACEUTICA NV2 citations72
US9265770B2Feb 23, 2016

1,2,5-substituted benzimidazoles as FLAP modulators

JANSSEN PHARMACEUTICA NV3 citations72
US8952177B2Feb 10, 2015

1,2,6-substituted benzimidazoles as FLAP modulators

JANSSEN PHARMACEUTICA NV4 citations72
US10947252B2Mar 16, 2021

Inhibitors of KEAP1-Nrf2 protein-protein interaction

JANSSEN PHARMACEUTICA NV3 citations71
US11254673B2Feb 22, 2022

Small molecule inhibitors of NF-κB inducing kinase

JANSSEN PHARMACEUTICA NV2 citations69
US12378254B2Aug 5, 2025

Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators

JANSSEN PHARMACEUTICA NV0 citations62
US9089569B2Jul 28, 2015

1,2,6-substituted benzimidazoles as flap modulators

JANSSEN PHARMACEUTICA NV3 citations62
US9067917B2Jun 30, 2015

1,2,5-substituted benzimidazoles as FLAP modulators

JANSSEN PHARMACEUTICA NV3 citations61
US7402680B2Jul 22, 2008

Fused heterocyclic compounds

JANSSEN PHARMACEUTICA NV4 citations61
US11897900B2Feb 13, 2024

Inhibitors of KEAP1-Nrf2 protein-protein interaction

JANSSEN PHARMACEUTICA NV0 citations60
US11427601B1Aug 30, 2022

Inhibitors of KEAP1-Nrf2 protein-protein interaction

JANSSEN PHARMACEUTICA NV0 citations60
US9695149B2Jul 4, 2017

1,2,6-substituted benzimidazoles as flap modulators

JANSSEN PHARMACEUTICA NV0 citations51
US9682971B2Jun 20, 2017

1,2,5-Substituted benzimidazoles as flap modulators

JANSSEN PHARMACEUTICA NV0 citations51
US7897771B2Mar 1, 2011

Fused heterocyclic compounds

JANSSEN PHARMACEUTICA NV0 citations51
US9682972B2Jun 20, 2017

1,2,5-substituted benzimidazoles as flap modulators

JANSSEN PHARMACEUTICA NV0 citations49
US9981909B2May 29, 2018

Serotonin receptor modulators

JANSSEN PHARMACEUTICA NV0 citations48
US10172856B2Jan 8, 2019

2,4-diaminopyrimidine derivatives as histamine H4 modulators

JANSSEN PHARMACEUTICA NV0 citations41

ORTHO MCNEIL PHARM INC

4 patents

CHAI WENYING

1 patent

ORTHO MCNEIL PHAMRACEUTICAL IN

1 patent

JOHNSON & JOHNSON PHARM RES

1 patent

CARRUTHERS NICHOLAS I

1 patent

BONAVENTURE PASCAL

1 patent